Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 29Breast Neoplasms 10Neoplasms 2Stage II Prostate Adenocarcinoma 1Salivary Gland Neoplasms 1Prostatectomy 1Prostate Cancer Metastatic Disease 1Ovarian Neoplasms 1Oligometastatic Prostate Carcinoma 1Metastatic Castration-resistant Prostate Cancer 1Highly Endocrine Responsive Operable Breast Cancer 1Cardiovascular Diseases 1Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

xinmailong 1pembrolizumab 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Sugars 1Pyruvic Acid 1Linseed Oil 1Gonadotropin-Releasing Hormone 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Cardiovascular Diseases × Gonadotropin-Releasing Hormone × Clear all
NCT04182594 2019-12-02

Cardiovascular Events in GnRH Agonist vs. Antagonist

Rabin Medical Center

Phase 2 Unknown
80 enrolled
Genitourinary

Cardiovascular Diseases, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡